131 related articles for article (PubMed ID: 19144092)
21. Late-onset neutropenia (LON) after low-dose rituximab treatment in living related kidney transplantation--single-center study.
Ishida H; Inui M; Furusawa M; Tanabe K
Transpl Immunol; 2013 Mar; 28(2-3):93-9. PubMed ID: 23353568
[TBL] [Abstract][Full Text] [Related]
22. ABO-incompatible adult liver transplantation when the anti-ABO antibody titer is high.
Shimoda M; Marubashi S; Dono K; Miyamoto A; Takeda Y; Umeshita K; Nagano H; Hoshida Y; Monden M
Hepatogastroenterology; 2009; 56(93):1174-7. PubMed ID: 19760964
[TBL] [Abstract][Full Text] [Related]
23. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea.
Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
Transplant Proc; 2008 Dec; 40(10):3772-7. PubMed ID: 19100487
[TBL] [Abstract][Full Text] [Related]
24. Rituximab as monotherapy for elicited xenoreactive antibody responses.
Gonzalez-Stawinski GV; Davis RD
J Heart Lung Transplant; 2006 Dec; 25(12):1462-6. PubMed ID: 17178342
[TBL] [Abstract][Full Text] [Related]
25. [Successful treatment of splenic lymphoma with villous lymphocytes by rituximab and laparoscopic splenectomy].
Fujita T; Asagoe K; Sakoda H
Rinsho Ketsueki; 2003 Apr; 44(4):249-53. PubMed ID: 12784658
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometric measurement of ABO antibodies in ABO-incompatible living donor kidney transplantation.
Yung GP; Valli PV; Starke A; Mueller RJ; Fehr T; Cesar-Ozpamir M; Schanz U; Weber M; Wüthrich RP; Seebach JD; Stussi G
Transplantation; 2007 Dec; 84(12 Suppl):S20-3. PubMed ID: 18162982
[TBL] [Abstract][Full Text] [Related]
27. ABO-incompatible transplantation: less may be more.
Montgomery RA; Locke JE
Transplantation; 2007 Dec; 84(12 Suppl):S8-9. PubMed ID: 18162992
[TBL] [Abstract][Full Text] [Related]
28. ABO-incompatible kidney transplantation with anti-CD20 monoclonal antibodies, intravenous immunoglobulin and plasmapheresis without splenectomy: a case report.
Imamura R; Ishiguro S; Shi Y; Namba Y; Ichimaru N; Isaka Y; Takahara S; Okuyama A
Xenotransplantation; 2006 Mar; 13(2):133-5. PubMed ID: 16623807
[TBL] [Abstract][Full Text] [Related]
29. Rituximab-induced changes in hematolymphoid tissues found at autopsy.
Cioc AM; Vanderwerf SM; Peterson BA; Robu VG; Forster CL; Pambuccian SE
Am J Clin Pathol; 2008 Oct; 130(4):604-12. PubMed ID: 18794054
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients.
Jordan SC; Peng A; Vo AA
Contrib Nephrol; 2009; 162():13-26. PubMed ID: 19001810
[TBL] [Abstract][Full Text] [Related]
31. Is administration of rituximab at 375 mg/m without splenectomy appropriate for ABO-incompatible renal transplant?
Mitsuhata N; Fujita R; Ito S; Mannami M; Kojima K
Am J Transplant; 2005 Dec; 5(12):3019; author reply 3020. PubMed ID: 16303019
[No Abstract] [Full Text] [Related]
32. Hand-assisted laparoscopic splenectomy in ABO-incompatible kidney transplant recipients.
Tojimbara T; Nakajima I; Nanmoku K; Ishii Y; Tonsho M; Yashima J; Kudo S; Kato Y; Kai K; Sannomiya A; Koyama I; Fuchinoue S; Teraoka S
Transplant Proc; 2008 Sep; 40(7):2336-8. PubMed ID: 18790228
[TBL] [Abstract][Full Text] [Related]
33. Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders.
Petereit HF; Rubbert-Roth A
Mult Scler; 2009 Feb; 15(2):189-92. PubMed ID: 18971221
[TBL] [Abstract][Full Text] [Related]
34. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.
Martin Mdel P; Cravens PD; Winger R; Kieseier BC; Cepok S; Eagar TN; Zamvil SS; Weber MS; Frohman EM; Kleinschmidt-Demasters BK; Montine TJ; Hemmer B; Marra CM; Stüve O
Arch Neurol; 2009 Aug; 66(8):1016-20. PubMed ID: 19667224
[TBL] [Abstract][Full Text] [Related]
35. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.
Ikegami T; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Harada N; Iguchi T; Hashimoto N; Maehara Y
Transplantation; 2009 Aug; 88(3):303-7. PubMed ID: 19667930
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic plasma exchange for desensitization prior to transplantation in ABO-incompatible renal allografts.
Sivakumaran P; Vo AA; Villicana R; Peng A; Jordan SC; Pepkowitz SH; Klapper EB
J Clin Apher; 2009; 24(4):155-60. PubMed ID: 19658162
[TBL] [Abstract][Full Text] [Related]
37. [The blood group incompatible living kidney transplantation].
Donauer J
MMW Fortschr Med; 2007 Aug; 149(31-32):27-8. PubMed ID: 17849782
[TBL] [Abstract][Full Text] [Related]
38. [Desensitization protocols in immunized living donor kidney transplant recipients].
Nocera A
G Ital Nefrol; 2009; 26(4):499-515. PubMed ID: 19644839
[TBL] [Abstract][Full Text] [Related]
39. Case report: diffuse splenic metastasis of occult breast cancer with incompatible blood group antigenic determinants.
Baranyay F
Acta Histochem; 2009; 111(4):343-8. PubMed ID: 19201455
[TBL] [Abstract][Full Text] [Related]
40. A single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function.
Kamburova EG; Koenen HJ; Borgman KJ; ten Berge IJ; Joosten I; Hilbrands LB
Am J Transplant; 2013 Jun; 13(6):1503-11. PubMed ID: 23570303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
